Filing Details
- Accession Number:
- 0000950170-24-030932
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-13 17:46:16
- Reporting Period:
- 2024-03-11
- Accepted Time:
- 2024-03-13 17:46:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1863127 | Tyra Biosciences Inc. | TYRA | Pharmaceutical Preparations (2834) | 831476348 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1880946 | Daniel Bensen | C/O Tyra Biosciences, Inc. 2656 State Street Carlsbad CA 92008 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-03-11 | 200 | $20.00 | 431,683 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
Billionaire Hedge Funds
